X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 2 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding X4 Pharmaceuticals, Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 98 | 2 | 90 | −6 |
| Shares | 100.6M | 267.6K | 99.8M | −497.7K (−0.5%) |
| Value | $67.3M | $179.1K | $73.2M | +$6.10M (+9.1%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acorn Capital Advisors, LLC | 7,310,650 | $5.36M | 2.89% |
| Atria Wealth Solutions, Inc. | 60,000 | $44.0K | 0.00% |
| Wolverine Trading, LLC | 39,663 | $32.1K | 0.00% |
| Cantor Fitzgerald, L. P. | 40,251 | $29.5K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 33,784 | $24.8K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 30,266 | $22.2K | 0.00% |
| Integrated Wealth Concepts LLC | 30,000 | $22.0K | 0.00% |
| Colony Group, LLC | 25,025 | $18.4K | 0.00% |
| JustInvest LLC | 22,258 | $16.3K | 0.00% |
| Ameriprise Financial Inc | 22,042 | $16.2K | 0.00% |
| CIBC World Markets Corp | 15,726 | $11.5K | 0.00% |
| Xponance, Inc. | 10,760 | $7.89K | 0.00% |
| HBK Sorce Advisory LLC | 10,459 | $7.67K | 0.00% |
| SBI Securities Co., Ltd. | 1,122 | $823 | 0.00% |
| EverSource Wealth Advisors, LLC | 41 | $30 | 0.00% |
Sold out (21)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 4,276,315 | $2.86M |
| Perceptive Advisors LLC | 3,545,454 | $2.37M |
| Sio Capital Management, LLC | 1,303,508 | $872.4K |
| Parkman Healthcare Partners LLC | 818,727 | $548.0K |
| Nuveen Asset Management, LLC | 498,745 | $333.8K |
| New Leaf Venture Partners, L.L.C. | 335,000 | $224.1K |
| Diametric Capital, LP | 288,552 | $193.1K |
| XTX Topco Ltd | 157,642 | $105.5K |
| Prelude Capital Management, LLC | 105,083 | $70.3K |
| K2 Principal Fund, L.P. | 89,158 | $59.7K |
| Amundi | 81,305 | $44.0K |
| CIBC Private Wealth Group, LLC | 45,000 | $30.1K |
| Verition Fund Management LLC | 44,355 | $29.7K |
| Bayesian Capital Management, LP | 38,400 | $25.7K |
| Victory Capital Management Inc | 14,927 | $9.99K |
| Two Sigma Securities, LLC | 12,093 | $8.09K |
| Federation des caisses Desjardins du Quebec | 2,000 | $1.34K |
| Capital Performance Advisors LLP | 760 | $509 |
| SRS Capital Advisors, Inc. | 503 | $337 |
| True Wealth Design, LLC | 486 | $326 |
| Advisor Group Holdings, Inc. | 400 | $268 |
Not filed for Q4 2024 yet (2)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| AJOVista, LLC | 257,644 | $172.4K |
| PEAK6 Investments LLC | 10,000 | $6.69K |